IRulya Therapeutics QNCX
NASDAQ QNCX
$34.68 -5.59 (-13.88%)
At close: Oct 21, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Change in Accured Expenses (2018 - 2026)

Updated

Analysis

Quince Therapeutics, Inc. (QNCX) Change in Accured Expenses (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.93 Mn
Mar 31, 2026 -7.16 Mn
Dec 31, 2025 5.30 Mn
Sep 30, 2025 -631,000.00
Jun 30, 2025 204,000.00
Mar 31, 2025 899,000.00
Dec 31, 2024 535,000.00
Sep 30, 2024 819,000.00
Jun 30, 2024 94,000.00
Mar 31, 2024 -381,000.00
Dec 31, 2023 -1.40 Mn
Sep 30, 2023 243,000.00
Jun 30, 2023 25,000.00
Mar 31, 2023 -844,000.00
Dec 31, 2022 -1.36 Mn
Sep 30, 2022 -290,000.00
Jun 30, 2022 -2.12 Mn
Mar 31, 2022 -2.89 Mn
Dec 31, 2021 -1.97 Mn
Sep 30, 2021 -107,000.00
API Access

Quince Therapeutics, Inc. Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=QNCX&period=max&api_key=YOUR_API_KEY